Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 4 25 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus CLINIMIX 4 25 5 SULFITE FREE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 4 25 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus CLINIMIX 4 25 5 SULFITE FREE IN DEXTROSE 5 IN PLASTIC CONTAINER.
CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER vs CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CLINIMIX 4.25/10 is a parenteral nutrition solution providing amino acids (4.25%) for protein synthesis and dextrose (10%) as a carbohydrate calorie source. The amino acids are used for tissue repair and growth, while dextrose provides energy via glycolysis and oxidative phosphorylation.
CLINIMIX 4.25/5 is a parenteral nutrition solution providing amino acids and dextrose for protein synthesis and energy metabolism. Amino acids serve as substrates for protein synthesis, while dextrose provides a source of glucose for cellular energy production via glycolysis and oxidative phosphorylation.
Intravenous infusion; typical adult dose is 500-2000 mL per day, providing 4.25 g/100 mL amino acids and 10 g/100 mL dextrose, infused at a rate not exceeding 100 mL/hour initially, adjusted based on metabolic and clinical response.
IV, dosage individualized based on protein and energy requirements. Typical adult dose: 1.5 g/kg/day of amino acids (4.25% solution) as part of total parenteral nutrition, infused at a rate not exceeding 0.1 g/kg/hour.
None Documented
None Documented
Amino acids: 0.5-2 hours (individual amino acids vary); dextrose: 1-2 hours (insulin-dependent); terminal half-life not defined due to continuous infusion.
Amino acids: variable, with terminal half-life of individual amino acids ranging from 0.5 to 3 hours. Clinical context: continuous infusion maintains steady-state levels; used for nutritional support.
Renal: 95-100% (as amino acids, glucose, and metabolites); minimal biliary/fecal elimination.
The components (amino acids and dextrose) are metabolized; excess nitrogen is excreted renally as urea (about 85-90%), with minor fecal loss (<5%). Dextrose is fully metabolized to CO2 and water, with negligible renal excretion.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition